HMOX1 and silicosis: Taken together with our earlier results, the strategy of HO-1 supplementation, which originates from monitoring serum HO-1 and ROS such as hydrogen peroxide in patients with silicosis, could offer a new treatment option by inhibiting the excess activation of ROS-ERK signaling.